Search

Your search keyword '"Dangond, Fernando"' showing total 15 results
Start Over Author "Dangond, Fernando" Publisher figshare
15 results on '"Dangond, Fernando"'

1. Additional file 6: of Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Author

Traboulsee, Anthony, Li, David, Cascione, Mark, Juanzhi Fang, Dangond, Fernando, and Miller, Aaron

Abstract

Figure S5. Proportion progressed at each year by ≥2 versus 0–1 active T2 lesions at 12 months. (a) Placebo/delayed treatment, ≥2 versus 0–1 T2 lesions at 12 months; (b) IFN β-1a 22 μg SC tiw, ≥2 versus 0–1 T2 lesions at 12 months; (c) IFN β-1a 44 μg SC tiw, ≥2 versus 0–1 T2 lesions at 12 months. (PDF 183 kb)

Published
2018
Full Text
View/download PDF

2. Additional file 1: of Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsingâ remitting multiple sclerosis at year 1

Author

Traboulsee, Anthony, Li, David, Cascione, Mark, Juanzhi Fang, Dangond, Fernando, and Miller, Aaron

Abstract

Table S1. Baseline characteristics of patients in the PRISMS-2 study (adapted from PRISMS Study Group. Lancet. 1998;352:1498â 504). (DOCX 15 kb)

Published
2018
Full Text
View/download PDF

3. Additional file 2: of Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Author

Traboulsee, Anthony, Li, David, Cascione, Mark, Juanzhi Fang, Dangond, Fernando, and Miller, Aaron

Abstract

Figure S2. Proportion with EDSS progression at each year in the placebo/delayed treatment and IFN β-1a 44 μg SC tiw groups by ≥4 versus 0 active T2 lesions at 6 months. (PDF 189 kb)

Published
2018
Full Text
View/download PDF

5. Additional file 3: of Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Author

Traboulsee, Anthony, Li, David, Cascione, Mark, Juanzhi Fang, Dangond, Fernando, and Miller, Aaron

Abstract

Table S1. (a) Performance of T2 lesions on predicting EDSS progression at Year 2 and Year 4. (b) Performance of T2 lesions on predicting relapse at Year 2 and Year 4. (DOCX 15Â kb)

Published
2018
Full Text
View/download PDF

7. Additional file 1: of Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Author

Traboulsee, Anthony, Li, David, Cascione, Mark, Juanzhi Fang, Dangond, Fernando, and Miller, Aaron

Subjects
3. Good health
Abstract

Figure S1. Proportion with EDSS progression at each year by ≥2 versus 0–1 active T2 lesions at 6 months. (a) Placebo/delayed treatment group; (b) IFN β-1a 22 μg SC tiw group; (c) IFN β-1a 44 μg SC tiw group. (PDF 258 kb)

8. Additional file 7: of Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Author

Traboulsee, Anthony, Li, David, Cascione, Mark, Juanzhi Fang, Dangond, Fernando, and Miller, Aaron

Subjects
3. Good health
Abstract

Figure S6. Proportion relapsed at each year by ≥2 versus 0–1 active T2 lesions at 12 months. (a) Placebo/delayed treatment group; (b) IFN β-1a 22 μg SC tiw group; (c) IFN β-1a 44 μg SC tiw group. (PDF 273 kb)

9. Additional file 1: of Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Author

Traboulsee, Anthony, Li, David, Cascione, Mark, Juanzhi Fang, Dangond, Fernando, and Miller, Aaron

Subjects
3. Good health
Abstract

Figure S1. Proportion with EDSS progression at each year by ≥2 versus 0–1 active T2 lesions at 6 months. (a) Placebo/delayed treatment group; (b) IFN β-1a 22 μg SC tiw group; (c) IFN β-1a 44 μg SC tiw group. (PDF 258 kb)

11. Additional file 7: of Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Author

Traboulsee, Anthony, Li, David, Cascione, Mark, Juanzhi Fang, Dangond, Fernando, and Miller, Aaron

Subjects
3. Good health
Abstract

Figure S6. Proportion relapsed at each year by ≥2 versus 0–1 active T2 lesions at 12 months. (a) Placebo/delayed treatment group; (b) IFN β-1a 22 μg SC tiw group; (c) IFN β-1a 44 μg SC tiw group. (PDF 273 kb)

12. Additional file 5: of Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Author

Traboulsee, Anthony, Li, David, Cascione, Mark, Juanzhi Fang, Dangond, Fernando, and Miller, Aaron

Subjects
3. Good health
Abstract

Figure S4. Proportion relapsed at each year by ≥2 versus 0–1 active T2 lesions at 6 months. (a) Placebo/delayed treatment group; (b) IFN β-1a 22 μg SC tiw group; (c) IFN β-1a 44 μg SC tiw group. (PDF 269 kb)

13. Additional file 4: of Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Author

Traboulsee, Anthony, Li, David, Cascione, Mark, Juanzhi Fang, Dangond, Fernando, and Miller, Aaron

Subjects
3. Good health
Abstract

Figure S3. Time to sustained EDSS progression by ≥2 versus 0–1 active T2 lesions at 6 months. (a) Placebo/delayed treatment group; (b) IFN β-1a 22 μg SC tiw group; (c) IFN β-1a 44 μg SC tiw group. (PDF 229 kb)

14. Additional file 5: of Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Author

Traboulsee, Anthony, Li, David, Cascione, Mark, Juanzhi Fang, Dangond, Fernando, and Miller, Aaron

Subjects
3. Good health
Abstract

Figure S4. Proportion relapsed at each year by ≥2 versus 0–1 active T2 lesions at 6 months. (a) Placebo/delayed treatment group; (b) IFN β-1a 22 μg SC tiw group; (c) IFN β-1a 44 μg SC tiw group. (PDF 269 kb)

15. Additional file 4: of Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Author

Traboulsee, Anthony, Li, David, Cascione, Mark, Juanzhi Fang, Dangond, Fernando, and Miller, Aaron

Subjects
3. Good health
Abstract

Figure S3. Time to sustained EDSS progression by ≥2 versus 0–1 active T2 lesions at 6 months. (a) Placebo/delayed treatment group; (b) IFN β-1a 22 μg SC tiw group; (c) IFN β-1a 44 μg SC tiw group. (PDF 229 kb)

Catalog

Books, media, physical & digital resources
See catalog results